| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |